• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人白细胞介素-2和干扰素-γ基因的瞬时表达受不同细胞亚群之间相互作用的调控。

Transient expression of human interleukin-2 and interferon-gamma genes is regulated by interaction between distinct cell subsets.

作者信息

Arad G, Ketzinel M, Tal C, Nussinovich R, Deutsch E, Schlesinger M, Gerez L, Kaempfer R

机构信息

Department of Molecular Virology, Hebrew University-Hadassah Medical School, Jerusalem, Israel.

出版信息

Cell Immunol. 1995 Feb;160(2):240-7. doi: 10.1016/0008-8749(95)80034-g.

DOI:10.1016/0008-8749(95)80034-g
PMID:7536635
Abstract

The level of transient expression of human IL-2 and IFN-gamma genes, we show, is regulated by dynamic interaction between two functionally distinct cell populations. One is able to express these genes, while the other, bearing one of several specific surface markers, actively inhibits their expression. Defined cell subsets were isolated from PBMC and tonsil cells using immunomagnetic beads coated with monoclonal antibodies directed against surface markers. Depletion of CD8, CD11a (Leu15), or Leu8 subsets led to a pronounced superinduction of IL-2 and IFN-gamma gene expression when the remaining cell population was stimulated with mitogen (PHA) or antigen (SEB). Thus, a 10-fold increase in production of IFN-gamma was observed after removal of CD11a (Leu15) cells constituting only a small percentage of the total cell population. By contrast, depletion of cells expressing CD19, a B cell marker, did not yield any superinduction. Conversely, CD8, CD11a (Leu15), or Leu8 cell subsets, but not CD19 cells, each inhibited the induction of IL-2 and IFN-gamma gene expression almost completely in depleted or total cell populations from which they were derived. Gene expression occurring within one cell subset could be effectively inhibited by cells from a second subset. Introduction of inhibitory cells (Leu8) into a population that actively expressed IL-2 and IFN-gamma mRNA resulted in an immediate cessation of gene expression. This suppression involves a soluble mediator, since the culture medium in which such cells were activated exerted a similarly effective inhibition.

摘要

我们发现,人白细胞介素-2(IL-2)和干扰素-γ(IFN-γ)基因的瞬时表达水平受两种功能不同的细胞群体之间动态相互作用的调节。其中一种能够表达这些基因,而另一种带有几种特定表面标志物之一,可积极抑制它们的表达。使用包被有针对表面标志物的单克隆抗体的免疫磁珠,从外周血单核细胞(PBMC)和扁桃体细胞中分离出特定的细胞亚群。当用丝裂原(PHA)或抗原(SEB)刺激剩余细胞群体时,去除CD8、CD11a(Leu15)或Leu8亚群会导致IL-2和IFN-γ基因表达明显超诱导。因此,在去除仅占总细胞群体一小部分的CD11a(Leu15)细胞后,观察到IFN-γ产量增加了10倍。相比之下,去除表达B细胞标志物CD19的细胞并未产生任何超诱导现象。相反,CD8、CD11a(Leu15)或Leu8细胞亚群,而非CD19细胞,几乎完全抑制了来自它们所源自的耗尽或总细胞群体中IL-2和IFN-γ基因表达的诱导。一个细胞亚群内发生的基因表达可被第二个亚群的细胞有效抑制。将抑制性细胞(Leu8)引入积极表达IL-2和IFN-γ mRNA的群体中会导致基因表达立即停止。这种抑制涉及一种可溶性介质,因为激活这些细胞的培养基也发挥了类似的有效抑制作用。

相似文献

1
Transient expression of human interleukin-2 and interferon-gamma genes is regulated by interaction between distinct cell subsets.人白细胞介素-2和干扰素-γ基因的瞬时表达受不同细胞亚群之间相互作用的调控。
Cell Immunol. 1995 Feb;160(2):240-7. doi: 10.1016/0008-8749(95)80034-g.
2
The potential to express or suppress human interleukin-2 and interferon-gamma genes is not restricted to distinct cell subsets.表达或抑制人类白细胞介素-2和干扰素-γ基因的能力并不局限于特定的细胞亚群。
Mol Immunol. 1990 Dec;27(12):1325-30. doi: 10.1016/0161-5890(90)90038-2.
3
Distinct pattern of IL-2 and IFN-gamma gene expression in CD4 and CD8 T cells: cytofluorometric analysis at a single cell level using non-radioactive probes.CD4和CD8 T细胞中白细胞介素-2和γ干扰素基因表达的独特模式:使用非放射性探针在单细胞水平上进行细胞荧光分析。
Cell Mol Biol (Noisy-le-grand). 1995 Nov;41(7):945-57.
4
Segregation of type 1 cytokine production in human peripheral blood lymphocytes: phenotypic differences between IFN-gamma and IL-2-producing cells in the CD8+ T cell subset.人外周血淋巴细胞中1型细胞因子产生的分离:CD8 + T细胞亚群中产生IFN-γ和IL-2的细胞之间的表型差异。
Eur J Immunol. 1998 Nov;28(11):3630-8. doi: 10.1002/(SICI)1521-4141(199811)28:11<3630::AID-IMMU3630>3.0.CO;2-6.
5
Regulation of human interleukin-2 and interferon-gamma gene expression by suppressor T lymphocytes.抑制性T淋巴细胞对人白细胞介素-2和γ-干扰素基因表达的调控
Scand J Immunol. 1991 May;33(5):593-605. doi: 10.1111/j.1365-3083.1991.tb02531.x.
6
Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis.在愈合期和进行性鼠利什曼病期间,体内CD4 +淋巴细胞产生干扰素γ、白细胞介素2、白细胞介素4和白细胞介素10 。
Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7011-5. doi: 10.1073/pnas.88.16.7011.
7
IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.白细胞介素-2受体阻断抑制人T细胞中晚期而非早期的γ干扰素和CD40配体表达:破坏γ干扰素产生的白细胞介素-12依赖性和非依赖性途径。
J Immunol. 2002 Sep 1;169(5):2736-46. doi: 10.4049/jimmunol.169.5.2736.
8
T cells made deficient in interleukin-2 production by exposure to staphylococcal enterotoxin B in vivo are primed for interferon-gamma and interleukin-10 secretion.在体内暴露于葡萄球菌肠毒素B后白介素-2生成存在缺陷的T细胞,易于分泌干扰素-γ和白介素-10。
Eur J Immunol. 1995 May;25(5):1148-53. doi: 10.1002/eji.1830250503.
9
Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lymphocytes: up-regulation of TNF, IFN-gamma and IL-2, in contrast to down-regulation of IL-6 production.非甾体抗炎药对人淋巴细胞中细胞因子的产生有不同的调节作用:肿瘤坏死因子、γ干扰素和白细胞介素-2上调,而白细胞介素-6的产生则下调。
Cytokine. 1995 May;7(4):372-9. doi: 10.1006/cyto.1995.0047.
10
Selective modulation of IFN-gamma mRNA stability by IL-12/NKSF.白细胞介素-12/自然杀伤细胞刺激因子对γ干扰素信使核糖核酸稳定性的选择性调控
Cell Immunol. 1994 Dec;159(2):140-51. doi: 10.1006/cimm.1994.1303.

引用本文的文献

1
Peptide antagonists of superantigen toxins.超抗原毒素的肽拮抗剂。
Mol Divers. 2004;8(2):113-20. doi: 10.1023/b:modi.0000025654.04427.44.
2
Cytokine gene expression in normal human lymphocytes in response to stimulation.正常人类淋巴细胞对刺激作出反应时的细胞因子基因表达。
Clin Diagn Lab Immunol. 1998 May;5(3):335-40. doi: 10.1128/CDLI.5.3.335-340.1998.